Products for Research Use Only
RegisterLogin

Lorlatinib (acetate)

CAT: 0804-HY-135509Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-135509Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lorlatinib (PF-06463922) acetate is a selective, orally active, brain-penetrant and ATP-competitive ROS1/ALK inhibitor with anticancer activity. Lorlatinib acetate has Kis of L1196M, respectively. Lorlatinib acetate targets to EML4-ALK, and inhibits ALK phosphorylation with IC50s of 15-43 nM (ALKL1196), 14-80 nM (ALKG1269A), 38-50 nM (ALK1151Tins), 77-113 nM (ALKG1202R), respectively[1][2][3].
CAS Number
1924207-18-0
Product Name Alternative
PF-06463922 (acetate)
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; Apoptosis; ROS Kinase
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lorlatinib-acetate.html
Smiles
CN1C(C#N)=C2C(CN(C)C(C3=C([C@@H](C)OC4=C(N)N=CC2=C4)C=C(F)C=C3)=O)=N1.OC(C)=O
Molecular Formula
C23H23FN6O4
Molecular Weight
466.46
References & Citations
[1]Zou HY, et al. PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models. Cancer Cell. 2015 Jul 13;28 (1) :70-81.|[2]Johnson TW, et al. Discovery of (10R) -7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4- (metheno) pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations. J Med Chem. 2014 Jun 12;57 (11) :4720-44.|[3]Zou HY, et al. PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking PF-02341066-resistant ROS1 mutations. Proc Natl Acad Sci U S A. 2015 Mar 17;112 (11) :3493-8
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 4

Chemical Information

Lorlatinib acetate
CAS Number1924207-18-0
PubChem CID124203822
IUPAC Nameacetic acid;(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile
Molecular FormulaC23H23FN6O4
Molecular Weight466.5
Topological Polar Surface Area147
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count0
Heavy Atom Count34
Formal Charge0
Complexity731
SMILES
C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C.CC(=O)O
InChI
InChI=1S/C21H19FN6O2.C2H4O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12;1-2(3)4/h4-7,9,11H,10H2,1-3H3,(H2,24,25);1H3,(H,3,4)/t11-;/m1./s1
InChIKey
BLNAIBLTPYGILH-RFVHGSKJSA-N
Chemical Structure
2D Structure
2D structure of Lorlatinib acetate
CAS: 1924207-18-0
CID: 124203822
Formula: C23H23FN6O4
MW: 466.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight466.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count0
Exact Mass466.17648140
Monoisotopic Mass466.17648140
Topological Polar Surface Area147 Ų
Heavy Atom Count34
Formal Charge0
Complexity731
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-12215-01Lorlatinib
HY-12215R-01Lorlatinib (Standard)
HY-166875SApramycin acetate-d7 (acetate)
HY-134716Methyl acetate-PEG1-methyl acetate
HY-W127616-01β-Sitosterol acetate, 40% (contains Campesterol acetate)
HY-P4091A-01LSD (acetate)
HY-P2483B-01Octaarginine (acetate)
HY-P10959A-01Macupatide (acetate)
HY-P10517A-01Sifuvirtide (acetate)
HY-P0013A-01Antide (acetate)

Alternative Products

CatalogName
ZBD20718Lorlatinib acetate
GTR19163173-01Lorlatinib
AR-L06198-01Lorlatinib 13CD3
CS-O-59447Lorlatinib-d6
C17977Lorlatinib (PF-6463922)
CS-CX-00760Lorlatinib 13C, d3
406533Lorlatinib (PF-06463922)
GTR19281223-01Lorlatinib impurity-1
RM-L151200-01Lorlatinib (Pf 06463922)
A14207-100Lorlatinib (PF-06463922) 100mg

Popular Products